Literature DB >> 2173842

Hilar malignancy: treatment with an expandable metallic transhepatic biliary stent.

J M LaBerge1, M Doherty, R L Gordon, E J Ring.   

Abstract

An expandable metallic transhepatic biliary endoprosthesis was used to treat 20 patients with hilar malignancy and isolated right and left intrahepatic ducts. In 12 patients, only one intrahepatic ductal system was drained; in eight patients, both systems were drained. In five patients, both systems were drained through a single transhepatic track by arrangement of two stents in a T configuration. The initial technical success rate in placing the stents and achieving internal drainage was 100%. Complications necessitating further intervention occurred in two of the 20 patients. Short-term clinical follow-up was available for 19 of the 20 patients. Two months after stent insertion, two patients complained of persistent jaundice, two patients died without jaundice, and 15 patients were free of symptoms of biliary obstruction. A variety of geometric configurations are possible with this endoprosthesis. The relative merits of these stent arrangements are discussed, and a new technique for placing the stents in a T configuration is described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173842     DOI: 10.1148/radiology.177.3.2173842

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Current management of biliary strictures.

Authors:  Jennifer G Hall; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

2.  Covered self-expanding transhepatic biliary stents: clinical pilot study.

Authors:  S A Thurnher; J Lammer; M M Thurnher; F Winkelbauer; O Graf; R Wildling
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

3.  Endoscopic and percutaneous intervention in malignant obstructive jaundice.

Authors:  R E England; D F Martin
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

4.  Wallstent misplacement into the paraumbilical vein during TIPS from the left hepatic vein: correction by placing a second stent through the mesh of the first stent.

Authors:  M P Ghysels; O Le Moine; J Devière; P Cuvelliez; F Rypens; M Adler; J L Struyven
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

5.  Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.

Authors:  Dimitrios Karnabatidis; Stavros Spiliopoulos; Paraskevi Katsakiori; Odissefs Romanos; Konstantinos Katsanos; Dimitrios Siablis
Journal:  World J Hepatol       Date:  2013-03-27

Review 6.  Palliation of malignant obstructive jaundice.

Authors:  G Garcea; S L Ong; A R Dennison; D P Berry; G J Maddern
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

7.  Percutaneous transhepatic stenting by Wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation.

Authors:  J I Bilbao; M Ruza; J M Longo; F Mansilla; A Picardi; V de Villa; F Pardo; J Sola; J Quiroga
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jul-Aug       Impact factor: 2.740

8.  Malignant biliary obstruction treated by Wallstents and Strecker tantalum stents: a retrospective review.

Authors:  C Ferro; F Perona; C Ambrogi; A Barile; R Cianni
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

9.  Percutaneous biliary drainage using open cell stents for malignant biliary hilar obstruction.

Authors:  Sun Jun Ahn; Jae Ik Bae; Tae Sun Han; Je Hwan Won; Ji Dae Kim; Kyu-Sung Kwack; Jae Hee Lee; Young Chul Kim
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.